Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 17.90% | -0.21% | 1.14% | 0.47% |
| Total Depreciation and Amortization | -2.74% | -0.92% | 0.21% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75% | -250.79% | 0.21% | -71.36% | -0.47% |
| Change in Net Operating Assets | -- | -- | 0.21% | -- | -- |
| Cash from Operations | 2.75% | -101.64% | -0.21% | 3.98% | 0.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.75% | -- | -- | -- | -- |
| Cash from Investing | -2.75% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00% | 48.37% | 0.00% |
| Total Debt Repaid | 0.00% | 13.64% | 0.00% | 25.85% | 0.00% |
| Issuance of Common Stock | 0.00% | 66.51% | 0.00% | 1,202.48% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -299.40% | 0.00% | -1,266.22% | 0.00% |
| Cash from Financing | -2.75% | 33.43% | 0.20% | 1,322.20% | -0.46% |
| Foreign Exchange rate Adjustments | -2.78% | 3,693.18% | 0.00% | -15.79% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 8.88% | 0.21% | 271.67% | 0.48% |
